arrow
P

Paola Pontrelli

Universita degli Studi di Bari Aldo Moro
H指数:32
被引数:3,109

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DARE to wear: digital health promotion and disease prevention using wearable devices

敢穿:利用可穿戴设备进行数字健康促进和疾病预防

2026-09-190
OAAI
Virtual screening-guided repurposing of fluorescent probes to detect EGFR expression in renal cells

虚拟筛选指导的荧光探针再利用以检测肾细胞中EGFR表达

2026-07-010
PRE
Polyphenol-rich extra-virgin olive oil influences bioenergetics and may modulate NLRP3 inflammasome in PBMCs from children and adolescents with obesity

富含多酚的特级初榨橄榄油影响生物能量学,并可能调节肥胖儿童和青少年外周血单核细胞中的NLRP3炎症小体

2026-05-090
OAAI
MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?

MBL2缺陷和IgA肾病在移植患者中:补体抑制总是有益的吗?

2026-02-180
PRE
Comparative psychological well-being evaluation among CKD patients on conservative therapy; dialysis; or kidney transplantation: a cross-sectional study
2026-01-260
OAAI
The multi-omic analysis identified CHI3L1 as a potential mediator of immune system deregulation in kidney transplant patients with chronic antibody-mediated rejection

多组学分析鉴定出CHI3L1是肾移植患者慢性抗体介导排斥反应中免疫系统失调的潜在介导因子。

2025-10-010
OAAI
A renal biopsy–anchored multi-marker signature involving AOPEP SNP-driven splicing, miR-27b-3p and glycated albumin for stratifying renal damage in type 2 diabetes

一种以肾活检为锚点的多标记物特征,涉及AOPEP SNP驱动的剪接、miR-27b-3p和糖化白蛋白,用于分型2型糖尿病中的肾损伤

2025-09-090
OAAI
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network)

多通路血液生物标志物用于靶向和监测认知及功能下降的多维预防(嵌套在IN-TeMPO研究中,该研究框架内属于世界范围内的FINGERS网络)

2025-05-070
OA
Unveiling spontaneous renal tubule-like structures from human adult renal progenitor cell spheroids derived from urine

揭示来源于尿液的人类成年肾祖细胞微球体中自发的肾小管样结构

2025-03-290
OA
Performance and limitations of a supervised deep learning approach for the histopathological Oxford Classification of glomeruli with IgA nephropathy
2023-12-015
OAAI
Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project
2023-11-0210
OAAI